Target intelligence / Profile preview

Stress-associated endoplasmic reticulum protein 1 (SERP1)

Target
SERP1
Molecular classification
Other (ER membrane-associated protein; not a receptor, enzyme, transporter, or canonical signal transducer)
01

Overview

Stress-associated endoplasmic reticulum protein 1 (SERP1), also called RAMP4, is an evolutionarily conserved membrane protein of the ER that is upregulated during ER stress and interacts directly with the Sec61 translocon complex[1][2][4]. It stabilizes nascent, unfolded, or misfolded membrane proteins during conditions of cellular stress, preventing their degradation in the ER[1][3][4]. SERP1 regulates aspects of protein translocation and glycosylation, including ensuring the correct processing of secretory and membrane proteins and the glycosylation of MHC class II-associated invariant chains[1][2][4]. Loss of SERP1 function leads to increased ER stress, defective insulin production, and impaired growth hormone response[4]. Clinically, altered expression is associated with cancer prognosis and certain metabolic or endocrine disorders[1][3][4]. SERP1 serves no known receptor, enzyme, or transporter function but is a critical ER scaffolding and quality control protein.

Other names
Ribosome-associated membrane protein 4 (RAMP4)Ysy6 (yeast homolog)FLJ43424Ribosome-attached membrane protein 4
02

Biological functions

Protein quality control during ER stressStabilization of unfolded/misfolded membrane proteins to prevent their degradationModulation of glycosylation (including N-glycosylation site selection and glycosylation of MHC class II-associated invariant chains)Regulation of ER stress response/unfolded protein response (UPR)Interaction with Sec61 translocon to influence protein translocation and secretionSupporting biosynthesis and processing of secretory proteins
03

Disease associations

Cancer (including glioblastoma, pancreatic cancer, and poor prognosis/immune infiltration correlations in skin cutaneous melanoma)Congenital hypothyroidismHyperinsulinemic hypoglycemia (various subtypes)Generalized thyroid hormone resistancePolyendocrine-polyneuropathy syndromePituitary hormone deficiencyObesity due to pro-opiomelanocortin deficiency
04

Safety considerations

General concern: Loss of function is associated with increased ER stress, impaired protein synthesis/secretion, growth retardation, metabolic disturbance
05

Biomarkers

Prognostic biomarker in cancers such as skin cutaneous melanoma and pancreatic ductal adenocarcinoma (low expression correlates with worse outcome)

Beyond the preview

Go deeper on Stress-associated endoplasmic reticulum protein 1 (SERP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stress-associated endoplasmic reticulum protein 1 (SERP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call